TELA Bio, Inc. (TELA) Misses Q2 EPS by 28c

TELA Bio, Inc. (NASDAQ: TELA) reported Q2 EPS of ($0.88), $0.28 worse than the analyst estimate of ($0.60). Revenue for the quarter came in at $10.4 million versus the consensus estimate of $10.12 million.

GUIDANCE:

TELA Bio, Inc. sees FY2022 revenue of $42-45 million, versus the consensus of $42.3 million.

For earnings history and earnings-related data on TELA Bio, Inc. (TELA) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Pembina joins proposed 1M bbl/day Alberta-to-coast pipeline plan
• General Mills (GIS) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 EPS Guidance